Advertisement
Advertisement

GUTS

GUTS logo

Fractyl Health, Inc. Common Stock

0.42
USD
Sponsored
+0.02
+5.00%
Feb 06, 15:51 UTC -5
Closed
exchange

After-Market

0.43

+0.01
+1.90%

GUTS Earnings Reports

Positive Surprise Ratio

GUTS beat 3 of 7 last estimates.

43%

Next Report

Date of Next Report
Mar 03, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.18
Implied change from Q3 25 (Revenue/ EPS)
--
/
-74.65%
Implied change from Q4 24 (Revenue/ EPS)
-100.00%
/
-65.38%

Fractyl Health, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, GUTS reported earnings of -0.71 USD per share (EPS) for Q3 25, missing the estimate of -0.32 USD, resulting in a -120.29% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.18 USD, with revenue projected to reach -- USD, implying an decrease of -74.65% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Fractyl Health, Inc. Common Stock reported EPS of -$0.71, missing estimates by -120.29%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.89%, changed from $1.13 before the earnings release to $1.12 the day after.
The next earning report is scheduled for Mar 03, 2026.
Based on 7 analysts, Fractyl Health, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement